Nathaniel J Barber1, Emmanuel O Ako1, Gregorz T Kowalik1, Mun H Cheang1, Bejal Pandya1, Jennifer A Steeden1, Shahin Moledina1, Vivek Muthurangu2. 1. From the Centre for Cardiovascular Imaging, UCL Institute of Cardiovascular Science, London, United Kingdom (N.J.B., E.O.A., G.T.K., M.H.C., J.A.S., V.M.); Great Ormond Street Hospital, London, United Kingdom (N.J.B., G.T.K., M.H.C., J.A.S., S.M., V.M.); and Bart's Heart Centre, London, United Kingdom (E.O.A., B.P.). 2. From the Centre for Cardiovascular Imaging, UCL Institute of Cardiovascular Science, London, United Kingdom (N.J.B., E.O.A., G.T.K., M.H.C., J.A.S., V.M.); Great Ormond Street Hospital, London, United Kingdom (N.J.B., G.T.K., M.H.C., J.A.S., S.M., V.M.); and Bart's Heart Centre, London, United Kingdom (E.O.A., B.P.). v.muthurangu@ucl.ac.uk.
Abstract
BACKGROUND: Conventional cardiopulmonary exercise testing can objectively measure exercise intolerance but cannot provide comprehensive evaluation of physiology. This requires additional assessment of cardiac output and arteriovenous oxygen content difference. We developed magnetic resonance (MR)-augmented cardiopulmonary exercise testing to achieve this goal and assessed children with right heart disease. METHODS AND RESULTS: Healthy controls (n=10) and children with pulmonary arterial hypertension (PAH; n=10) and repaired tetralogy of Fallot (n=10) underwent MR-augmented cardiopulmonary exercise testing. All exercises were performed on an MR-compatible ergometer, and oxygen uptake was continuously acquired using a modified metabolic cart. Simultaneous cardiac output was measured using a real-time MR flow sequence and combined with oxygen uptake to calculate arteriovenous oxygen content difference. Peak oxygen uptake was significantly lower in the PAH group (12.6±1.31 mL/kg per minute; P=0.01) and trended toward lower in the tetralogy of Fallot group (13.5±1.29 mL/kg per minute; P=0.06) compared with controls (16.7±1.37 mL/kg per minute). Although tetralogy of Fallot patients had the largest increase in cardiac output, they had lower resting (3±1.2 L/min per m2) and peak (5.3±1.2 L/min per m2) values compared with controls (resting 4.3±1.2 L/min per m2 and peak 6.6±1.2 L/min per m2) and PAH patients (resting 4.5±1.1 L/min per m2 and peak 5.9±1.1 L/min per m2). Both the PAH and tetralogy of Fallot patients had blunted exercise-induced increases in arteriovenous oxygen content difference. However, only the PAH patients had significantly reduced peak values (6.9±1.3 mlO2/100 mL) compared with controls (8.4±1.4 mlO2/100 mL; P=0.005). CONCLUSIONS: MR-augmented cardiopulmonary exercise testing is feasible in both healthy children and children with cardiac disease. Using this novel technique, we have demonstrated abnormal exercise patterns in oxygen uptake, cardiac output, and arteriovenous oxygen content difference.
BACKGROUND: Conventional cardiopulmonary exercise testing can objectively measure exercise intolerance but cannot provide comprehensive evaluation of physiology. This requires additional assessment of cardiac output and arteriovenous oxygen content difference. We developed magnetic resonance (MR)-augmented cardiopulmonary exercise testing to achieve this goal and assessed children with right heart disease. METHODS AND RESULTS: Healthy controls (n=10) and children with pulmonary arterial hypertension (PAH; n=10) and repaired tetralogy of Fallot (n=10) underwent MR-augmented cardiopulmonary exercise testing. All exercises were performed on an MR-compatible ergometer, and oxygen uptake was continuously acquired using a modified metabolic cart. Simultaneous cardiac output was measured using a real-time MR flow sequence and combined with oxygen uptake to calculate arteriovenous oxygen content difference. Peak oxygen uptake was significantly lower in the PAH group (12.6±1.31 mL/kg per minute; P=0.01) and trended toward lower in the tetralogy of Fallot group (13.5±1.29 mL/kg per minute; P=0.06) compared with controls (16.7±1.37 mL/kg per minute). Although tetralogy of Fallot patients had the largest increase in cardiac output, they had lower resting (3±1.2 L/min per m2) and peak (5.3±1.2 L/min per m2) values compared with controls (resting 4.3±1.2 L/min per m2 and peak 6.6±1.2 L/min per m2) and PAH patients (resting 4.5±1.1 L/min per m2 and peak 5.9±1.1 L/min per m2). Both the PAH and tetralogy of Fallot patients had blunted exercise-induced increases in arteriovenous oxygen content difference. However, only the PAH patients had significantly reduced peak values (6.9±1.3 mlO2/100 mL) compared with controls (8.4±1.4 mlO2/100 mL; P=0.005). CONCLUSIONS: MR-augmented cardiopulmonary exercise testing is feasible in both healthy children and children with cardiac disease. Using this novel technique, we have demonstrated abnormal exercise patterns in oxygen uptake, cardiac output, and arteriovenous oxygen content difference.
Authors: Jo Howard; April E Slee; Simon Skene; Baba Inusa; Jamie Kawadler; Michelle Downes; Johanna Gavlak; Melanie Koelbel; Hanne Stotesbury; Maria Chorozoglou; Susan Tebbs; Subarna Chakravorty; Moji Awogbade; David C Rees; Atul Gupta; Patrick B Murphy; Nicholas Hart; Sati Sahota; Carol Nwosu; Maureen Gwam; Dawn Saunders; Vivek Muthurangu; Nathaniel Barber; Emmanuel Ako; Swee Lay Thein; Melanie Marshall; Isabel C Reading; Man Ying Edith Cheng; Fenella J Kirkham; Christina Liossi Journal: Trials Date: 2018-01-22 Impact factor: 2.279
Authors: Toby Rogers; Kanishka Ratnayaka; Jaffar M Khan; Annette Stine; William H Schenke; Laurie P Grant; Jonathan R Mazal; Elena K Grant; Adrienne Campbell-Washburn; Michael S Hansen; Rajiv Ramasawmy; Daniel A Herzka; Hui Xue; Peter Kellman; Anthony Z Faranesh; Robert J Lederman Journal: J Cardiovasc Magn Reson Date: 2017-07-27 Impact factor: 5.364
Authors: Adrianus J Bakermans; Jason N Bazil; Aart J Nederveen; Gustav J Strijkers; S Matthijs Boekholdt; Daniel A Beard; Jeroen A L Jeneson Journal: Front Physiol Date: 2017-11-27 Impact factor: 4.566
Authors: Pia Sjöberg; Sebastian Bidhult; Jelena Bock; Einar Heiberg; Håkan Arheden; Ronny Gustafsson; Shahab Nozohoor; Marcus Carlsson Journal: Eur Radiol Date: 2018-04-17 Impact factor: 5.315
Authors: David G Kiely; David Levin; Paul Hassoun; David D Ivy; Pei-Ni Jone; Jumaa Bwika; Steven M Kawut; Jim Lordan; Angela Lungu; Jeremy Mazurek; Shahin Moledina; Horst Olschewski; Andrew Peacock; Goverdhan Dutt Puri; Farbod Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin Jr Van Beek; Anton Vonk-Noordegraaf; Rebecca R Vanderpool; John Wort; Lan Zhao; Jim Wild; Jens Vogel-Claussen; Andrew J Swift Journal: Pulm Circ Date: 2019-03-18 Impact factor: 3.017